BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30125973)

  • 1. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
    Swain SS; Paidesetty SK; Dehury B; Sahoo J; Vedithi SC; Mahapatra N; Hussain T; Padhy RN
    J Cell Biochem; 2018 Dec; 119(12):9838-9852. PubMed ID: 30125973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple docking analysis and
    Halder ST; Dhorajiwala TM; Samant LR
    Int J Mycobacteriol; 2019; 8(3):229-236. PubMed ID: 31512598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].
    Kai M
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):221-6. PubMed ID: 15508724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase in Mycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy.
    Chaitanya V S; Das M; Bhat P; Ebenezer M
    J Cell Biochem; 2015 Oct; 116(10):2293-303. PubMed ID: 25833404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
    Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
    Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene.
    Kai M; Matsuoka M; Nakata N; Maeda S; Gidoh M; Maeda Y; Hashimoto K; Kobayashi K; Kashiwabara Y
    FEMS Microbiol Lett; 1999 Aug; 177(2):231-5. PubMed ID: 10474189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of natural compounds on Dihydropteroate synthase of
    Khan M; Khan S; Bushara NZA; Ali R; Tabassum Z; Ishrat R; Marouf HA; Sherwani S; Mirza S; Haque S
    J Biomol Struct Dyn; 2023; 41(23):13857-13872. PubMed ID: 37070201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Burden and Current Therapeutical Status of Leprosy with Special Emphasis on Phytochemicals.
    Swain SS; Sahoo G; Mahapatra PK; Panda SK
    Curr Top Med Chem; 2022; 22(19):1611-1625. PubMed ID: 34503409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.
    Williams DL; Spring L; Harris E; Roche P; Gillis TP
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1530-7. PubMed ID: 10817704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A theoretical study of chemical bonding and topological and electrostatic properties of the anti-leprosy drug dapsone.
    Rajendran ND; Mookan N; Samuel I; Mookan SB; Munusamy G; Gurudeeban S; Kaliamurthi S
    J Mol Model; 2020 May; 26(6):138. PubMed ID: 32415338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae.
    Swain SS; Paidesetty SK; Dehury B; Das M; Vedithi SC; Padhy RN
    Sci Rep; 2020 Apr; 10(1):6839. PubMed ID: 32322091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
    Nakata N; Kai M; Makino M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 17. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
    Lopez-Roa RI; Fafutis-Morris M; Masanori M
    Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.